Source file signed link, expires in 15 minutes
Extracted text 14
Page 1
Company
Update
1H 2026
PRIVATE & CONFIDENTIAL
Page 2
Company Structure
PT Ekon Prima Dra. Hetty Soetikno PT Cakra Universal Persada PT Vita Magna Trinita Public
8,99% 20,98% 20,98 % 23,98% 25,07%
Distribution & Medical Device
75.00% 51.00%
Distributor Distributor Marketing and Sales Manufacturer Digital Platform
of pharmaceuticals, of pharmaceuticals and of medical devices and of medical devices to aggregate demand on
medical devices, and health products marketing of prescription drugs at
health products for both in Cambodia pharmaceuticals marketplace
regular and JKN (BPJS) 2
market in Indonesia
Est. 1980 Est. 2018 Est. 1981 Est. 2020 Est. 2022
PRIVATE & CONFIDENTIAL 2
Page 3
With over 45 years of expertise, Medela Potentia has transformed into one of
Milestone Indonesia’s premier integrated distribution platforms, delivering a diverse range of
products nationwide — including our own line of manufactured medical devices
1980 1981 2011 2018 2022 2024 2025
• 1980: Established as a trading • 1981: acquired to • 2011: ▪ 2018: established in ▪ 2022: established ▪ 2024: established as • 2025: Medela
company focus on Pharmaceutical strengthen our established as a Cambodia, marking as a pharmacy a medical device Potentia Initial
distribution holding MP’s first international aggregator to manufacturer Public Offering
• 1996: repositioned as a partner to company expansion capture growing
global healthcare players • 2011: repositioned
as a sales & e-commerce ▪ 2025: first export
• 2003: implemented ERP system ▪ 2020: implemented demand.
marketing arm for ERP system and
and launched analytical business medical devices and
platform analytical business
launched its own platform
• 2011: expanded into consumer brand, Stardec.
product distribution ▪ 2023: expand new
• 2023: expanded into cosmetic, branches
beauty and baby products
distribution
• 2023: Enhanced digital offerings
through GPOS
PRIVATE & CONFIDENTIAL 3
Page 4
Dedicated and experienced senior leadership team
Management team with extensive experience, deep knowledge, and strong relationships
with key principals and customers
Stanley Ch. Budihardja Lukas Setia Atmaja Juliwaty Edbert Orotodan Wimala Widjaja Harris Lesmana Tjhin
Commissioner Independent Commissioner President Director Director Director President Director of DD
Concurrently serve as Commissioner Indonesian Citizen Concurrently serve as AAM Director Concurrently serve AAM Concurrently serve as KITA Indonesian Citizen
of DD and DMM. and DAC Director. Commissioner. Commissioner.
Indonesian Citizen Indonesian Citizen Indonesian Citizen Indonesian Citizen
Kansy W. Stephen Febianto Lim Budi Tom Kimson Luong Chan Huy Ruth Retno Dewi
Ivan Setiadi
Director OF DD Director of AAM Director of DAC Director of DAC Director of DAC Director of KITA
General Manager of DAC
Indonesian Citizen Concurrently serve as Indonesian Citizen Concurrently serve as Cambodian Citizen Cambodian Citizen Indonesian Citizen
Director of DMM. Director of AAM.
Indonesian Citizen Indonesian Citizen
PRIVATE & CONFIDENTIAL 4
Page 5
Driving Growth Through Network Expansion
Nationwide, Interconnected Distribution Network Supporting the Growth of Indonesia's Healthcare System
INDONESIA CAMBODIA Our strong commitment
Our Infrastructure1 Our Infrastructure1
35 Retail Warehouses
to highest compliance
3 Branches
35 Sales Office (Branch)
1 National Distribution Center (NDC)
3 Representative Sales Office
2 National Distribution Center (NDC)
2 Retail Warehouses
>800 Sales force >40 Sales force
Our Capacity1 Our Capacity
>75,000 m³ storage capacity 1,800 m³ storage capacity
>2,000 m³ cold chain capacity
Our Sale’s Channels
>4,000 >23,000
Clinics Pharmacies
>50,000 >3,000
Modern Trade Government
Institutions
>3,200
Hospitals >1,300
PBF & PAK
>20,000
Others
PRIVATE & CONFIDENTIAL 5
Page 6
Expand Margin through Diversification
into Medical Devices
Business Model Manufacturing Facility
Own
Product
Agency
• Inauguration: December
21st, 2023
Distribution • Location: Jababeka II
• Land area: 5,985 sqm • Storage area: 1,295 sqm (~1500 pallet)
• Building area: 4,800 sqm • ISO 13485 : Wound care and surgical
• Production area: 3,600 sqm supplies
• Provide end to end solution for customer
✔Strengthen own product business
and business partners
✔Government implemented a national health transformation to increase
• Leveraging our relationship with channel resilience in the medical device sector by supporting domestic manufacturing
and healthcare professional ✔Priority listing in the e-Katalog is given for products with a min. domestic
content of 40%, based on TKDN and BMP, fully implemented starting April 2022
PRIVATE & CONFIDENTIAL 6
Page 7
External Awards and Recognitions
S1 2026 Update
Public
Relations
Indonesia Digital Marketing Indonesia Best CEO Award Indonesia Top Digital PR Indonesia Top Companies
Champions with Distinction Award Recognition
SWA Media Group & Business Digest SWA Media Group & Dunamis Info Brand & Tras n Co Bloomberg & Indonesia Data
PT Karsa Inti Tuju Askara (GoApotik) The CEO of PT Medela Potentia Tbk, Mr. PT Medela Potentia Tbk was recognized PT Medela Potentia Tbk has been
received an Excellent distinction for its Krestijanto Pandji, was honored with the with the Indonesia Top Digital PR Award honoured with the Indonesia Top
success in improving marketing and sales Best CEO with Distinction award, the 2026, achieving a total score of 83.39% Companies Recognition 2026 in the "Top
performance. GoApotik achieved the highest recognition bestowed upon across Digital Media, Digital Sentiment, Company in Resilient Healthcare Supply
highest final score (88.9), outperforming corporate leaders demonstrating and Digital Awareness. Chain & Distribution Excellence" category.
several other participating companies. outstanding leadership excellence.
PRIVATE & CONFIDENTIAL 7
Page 8
S1 2026 Summary:
Sustain Growth Amid Current Uncertainties
Maintain Overall
Revenue Growth Strong Profit Growth
New Principals
IDR 8.2T IDR 226B
in Each Business Segment
+10.1% +12.6%
Medical Device Own Good Progress in Digital &
Manufacturing Products: AI Projects to improve Continue The Commitment
Continue High Growth Efficiency and Optimization to Sustainability
Momentum
PRIVATE & CONFIDENTIAL 8
Page 9
Growth Momentum Continues: Strong Top-Line, Improving
Bottom-Line Efficiency
In IDR Bio, unless otherwise stated
Net Sales Gross Profit EBITDA Net Profit
1,000
9, 000
4.0%
500 4.1%
9.6%
400
9.3% 10.0%
3.9%
900
2.8%
450
8, 000 3.0%
3.9%
350
2.7%
800
400
7, 000
5.0%
3.7%
2.5%
300
700
350
6, 000
Gr 600
0.0%
300
3.5%
250
2.0%
5, 000
+10.1%
500
250 3.3%
200
4, 000
8,171 -5.0%
1.5%
7,420 Gr 762
400
200
713 +6.8% Gr
3.1%
150
3, 000
-10.0%
325 Gr
292 +11.2%
300
+12.6%
150
226
1.0%
2, 000
200
100
2.9%
100
200
-15.0%
0.5%
2.7%
1, 000
50
100
50
- - -20.0%
- 2.5%
- 0.0%
S1'25 S1'26 S1'25 S1'26 S1'25 S1'26 S1'25 S1'26
Gross Profit %GM to NS EBITDA %EBITDA to NS PAT %Net Profit to NS
Consolidated
Double digit Top-line Lower %GP due to increasing EBITDA higher net profit
Growth principal and product margin trend growth than net sales
portfolio mix growth
Source : PT Medela Potentia Tbk and its subsidiaries unaudited S1’26 financial report
PRIVATE & CONFIDENTIAL 9
Page 10
Distribution Business – Update S1 2026
Infrastructures Development System Development New Principals
New Medan Warehouse 2026: Focus on Supply Chain Optimization
• Acquired: 2023 Forecast Accuracy
• Land size: 9,258m2
• Facilities: 2000 pallet
• Build Progress: 95%
• Estimated Go Live: Q4 2026
Data-driven Planning model
to Improve Productivity and
Optimization
100%
5 New Principals
Joined in 1H 2026
• Feature: Anaplan with AI FY 24 FY 25 1H 26
Optimizer Planning System
• Improvement Result: Out of Stock
New Land NDC2 – Jababeka I
• Acquired: August 2025 • Forecast Accuracy 2%
• Land size: 2,7 Ha incremental
PLAN • Plan: Build Cold Storage, Start • Out Of Stock reduction Ethical Consumer Medical
April 2026 – Go Live Q2 2027 • Transport cost efficiency FY 24 FY 25 1H 26 Pharma Health Device
• S1 2026 : Final Design Draft
Electric Vehicle Van Project
• S1-2026
Digital algorithm to Drive
Warehouse Productivity 1.2 00.000
1.0 00.000
Warehouse Operations 500
450
400
1 3 1
• Go Live April 2026 • Feature: Suggestion system 800 .000
350
300
• Trial & Analysis 1 unit
600 .000 250
to optimize order picking 400 .000
200
150
• In-Town Coverage operations 200 .000
100
50
• Plan S2-2026 • Improvement Result:
0 0
FY 24 FY 25 1H 26
• Add units for Jabotabek • Incremental Output with Sales Order
Branches no additional man power Man Power
PRIVATE & CONFIDENTIAL 10
Page 11
Medical Device Own Product – Update S1 2026
Medical Device Manufacturing Update
Growing Total Sales and Deca Metric Medica:
Product Portfolio Hospital Coverage Production Output
20.000 Coverage 500
+12% Total
15.000 Output
400 Production Output:
10.000 +8%
Sales • Own Brand (Deca)
+34% 300
5.000 • 3rd Party OEM
- 200 (start 2H 2024)
1H 25 1H 26 1H 25 1H 26
SALES COVERAGE
New SKUs Launched 1H 2026 Export Market
Plan S2 2026 – Own Product
Cambodia:
• First Export 5 Agustus 2025
• New Launched Products: 4-5
(Decafix, Decamed T)
Brands, Focus on Wound Care
• Plan Repeat: Q3 2026
and OR Solution
• New Export exploration –
ASEAN & Africa
Stardec DecaCare 5 Liter Stardec DecaFoam
PRIVATE & CONFIDENTIAL 11
Page 12
Digital B2B – S1 2026 Update:
Growing Revenue and Coverage Reach
Toserba S1 2026 Results
Principals
Coverage
300.000
+15% Value Added Services in
14.500
14.000
250.000 Collaboration with
13.500
Principals AAM 13.000
200.000
150.000
100.000
Sales
+20%
18
12.500
12.000
11.500
11.000
Principals (3 new)
S1 25
SALES
S1 26
COVERAGE
40 Brands (3 new)
2026 Strategic Objectives: Excellence & Expansion
• Key Objective: Increase digital B2B coverage and sales contribution by double-
digit growth through continuous operational excellence and commercial
Vet Others Hospital Clinics Apotek expansion.
• Operational Excellence: Improve pricing and promotion features (done S1
2026) and expand channels through HIS integration (continue in S2 2026).
Active: >200 Active: >900 Active: >900 Active: >1,200 Active: >11,500 • Commercial Expansion: Deepen brand collaborations and aggressively grow
Toserba sales and expand digital B2B platform to new channels.
PRIVATE & CONFIDENTIAL 12
Page 13
Delivering a Better Healthcare:
Commitment to ESG S1 2026 Update
Environmental Social Governance
Solar Panel Implementation Consistency in Action: PT Anugrah Argon
Medica and BPOM Continue Strengthening
Good Distribution Practice (CDOB)
• 8.505 people impacted. Implementation Nationwide
• 56 community-focused activities. S1 2026: 8 Cities | 836 Pharmacists
• 27 cities. 18 provinces. 6 islands.
Implementation of renewable energy by installing
a 90 kWp rooftop solar power system at the
Tangerang Branch.
EV Implementation
• 13 Cities
• 15 Branches
• 106 EV Bikes
• 1 EV Car
2026 Estimation: 12 Cities +1000 Partners
PRIVATE & CONFIDENTIAL 13
Page 14
Company Strategy S2 2026
Continue Driving Business Growth
1 • New Principal Exploration: Existing & New Segments
• Strengthen distribution coverage: OOP & BPJS Market, including new channel exploration
• Exploring prudently for presence in some countries within ASEAN
Strengthening and Modernizing Distribution System
2 • Capacity Expansion: Cold Chain & Non Cold Chain
• AI implementation in Business Process: Growth Exploration, Improve Productivity & Accuracy
• Exploration of Automatic System in Warehouse Infrastructure
Expanding Medical Device Portfolio
3 • Strengthen Own Product “Stardec” Portfolio: New Products Launch
• Continue exploring export market for “Stardec” own product to countries within ASEAN & Africa Region
• Expanding “Agency” Product Portfolio: Orthopedics, Minimally Invasive Surgery, and Oncology
Commitment to ESG
4 • Climate and Energy: Lower Emission & Renewable Energy
• Continue the Community Engagement & Contribution thru Argon Peduli
PRIVATE & CONFIDENTIAL 14
Names mentioned 15 people and organisations named in the text · linked when the evidence is strong
unresolved
person
Indonesian Citizen
· Commissioner
p.4
unresolved
person
Concurrently
· Director
p.4
unresolved
org
PT Karsa Inti Tuju Askara
p.7
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.